Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Minimally Invasive Surgery Market to Grow from USD 94.45 Billion in 2025 to USD 199.30 Billion by 2030, at a CAGR of 16.1% – MarketsandMarkets™

globenewswire.com
MDT Medtronic is listed as a major participant in the growing minimally invasive surgery market, indicating potential for growth but no specific positive or negative news. JNJ Johnson & Johnson is identified as a key player in the expanding minimally invasive surgery market, suggesting involvement in a growing sector without specific sentiment. ZBH Zimmer Biomet is mentioned as a major participant in the minimally invasive surgery market, indicating its role in a growing industry but without specific sentiment. ISRG Intuitive Surgical is a major participant in the expanding minimally invasive surgery market, particularly in robotic-assisted surgery, which is a key growth driver. STRL Stryker is listed as a major participant in the growing minimally invasive surgery market, indicating its presence in an expanding sector without specific sentiment. BSX Boston Scientific Corporation is named as a major market participant in the expanding minimally invasive surgery sector, suggesting involvement in a growing industry. ABT Abbott is identified as a major player in the minimally invasive surgery market, indicating its participation in a growing industry without specific sentiment. GEHC GE HealthCare is listed as a major participant in the minimally invasive surgery market, suggesting its role in a growing sector but without specific sentiment. TFX Teleflex Incorporated is mentioned as a major participant in the expanding minimally invasive surgery market, indicating its presence in a growing industry. CNMD CONMED Corporation is identified as a major participant in the expanding minimally invasive surgery market, suggesting involvement in a growing industry. GMED Globus Medical, Inc. is mentioned as a major participant in the minimally invasive surgery market, indicating its presence in a growing sector without specific sentiment.

Minimally Invasive Surgery Market to Grow from USD 94.45 Billion in 2025 to USD 199.30 Billion by 2030, at a CAGR of 16.1% – MarketsandMarkets™ Delray Beach, FL, Aug. 12, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global minimally invasive surgery market will grow from USD 94.45 billion in 2025 to USD 199.30 billion by 2030, at a CAGR of 16.1% during the forecast period. Market growth is fueled by the increasing preference for minimally invasive procedures that offer faster recovery, shorter hospital stays, less postoperative pain, and improved clinical outcomes. Continuous advancements in robotic-assisted surgery, AI-enabled imaging, 3D visualization, precision surgical instruments, and image-guided technologies are further accelerating adoption across multiple surgical specialties. Rising chronic disease prevalence, expanding geriatric populations, increasing outpatient surgical procedures, and growing healthcare infrastructure investments are expected to further strengthen market growth worldwide.

Get PDF Brochure - Market Data & Segmentation: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=787

Key Market Highlights

Why This Market Matters

Minimally invasive surgery has transformed modern healthcare by enabling surgeons to perform complex procedures through smaller incisions while reducing surgical trauma, postoperative pain, infection risk, and recovery time. As healthcare providers increasingly focus on improving patient outcomes and reducing treatment costs, minimally invasive procedures are becoming the preferred alternative to conventional open surgeries across specialties including gastrointestinal, gynecological, urological, orthopedic, cardiothoracic, neurological, and oncological surgery. Continuous innovation in robotics, advanced visualization systems, precision instruments, and AI-assisted navigation is further expanding the scope and effectiveness of minimally invasive interventions.

Market Overview

The minimally invasive surgery market continues to experience rapid expansion as hospitals, specialty clinics, and ambulatory surgical centers increasingly invest in advanced surgical technologies to improve clinical efficiency and patient outcomes. The market is evolving through the adoption of robotic-assisted surgery, advanced imaging systems, endoscopic technologies, electrosurgical devices, and integrated digital surgical platforms. While high capital investment, lengthy purchasing cycles, reimbursement uncertainties, and evolving regulatory requirements remain key challenges, ongoing technological innovation and expanding healthcare infrastructure continue to support long-term market growth.

Analyst Perspective

The future of minimally invasive surgery lies in intelligent surgical ecosystems that combine robotics, artificial intelligence, advanced visualization, digital navigation, and real-time clinical data. As ambulatory surgical centers increasingly adopt robotic-assisted procedures and healthcare systems continue shifting toward value-based care, manufacturers are investing in compact robotic platforms, software-driven surgical guidance, digital workflow integration, and surgeon training programs. Companies that successfully combine precision technologies with affordability and workflow efficiency are expected to strengthen their competitive positions during the coming decade.

Speak to Our Analyst - Get Custom Insights: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=787

Segment Analysis

By product, imaging & visualization systems are expected to register the highest growth during the forecast period. Within this category, ultrasound systems accounted for the largest market share in 2024 owing to their real-time imaging capabilities, radiation-free operation, affordability, portability, and expanding applications across multiple minimally invasive procedures.

By application, the urological surgery segment is projected to witness the highest CAGR during the forecast period due to the increasing prevalence of prostate cancer, bladder cancer, renal disorders, and growing adoption of laparoscopic and robotic-assisted urological procedures. Meanwhile, gastrointestinal & abdominal surgery continues to account for the largest application share in the minimally invasive surgery market.

Regional Analysis

The Asia Pacific region is expected to register the highest CAGR during the forecast period, driven by rapidly aging populations, increasing prevalence of chronic diseases, expanding healthcare infrastructure, rising government investments, and growing adoption of advanced surgical technologies. Countries such as China and India are witnessing substantial increases in laparoscopic procedures and robotic-assisted surgeries as hospitals continue modernizing surgical capabilities and improving access to minimally invasive treatment options.

Key Industry Trends

Competitive Landscape

The minimally invasive surgery market is moderately consolidated, with the leading five companies collectively accounting for 25%–50% of the global market. Major market participants include Medtronic (Ireland), Johnson & Johnson (US), Siemens Healthineers AG (Germany), Zimmer Biomet (US), Intuitive Surgical Operations, Inc. (US), Stryker (US), Boston Scientific Corporation (US), Abbott (US), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), FUJIFILM Corporation (Japan), Olympus Corporation (Japan), Smith+Nephew (UK), KARL STORZ SE & Co. KG (Germany), Teleflex Incorporated (US), CooperSurgical, Inc. (US), CONMED Corporation (US), Getinge AB (Sweden), Globus Medical, Inc. (US), and B. Braun SE (Germany). Companies continue strengthening their market positions through product innovation, acquisitions, regulatory approvals, strategic collaborations, and expansion of robotic-assisted surgical technologies.

Related Reports

Surgical Robots Market

Endoscopy Equipment Market